{"count": 13, "results": [{"_id": "38052777", "pmid": 38052777, "pmcid": "PMC10698150", "title": "Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux", "journal": "Sci Rep", "authors": ["Phadwal K", "Tan X", "Koo E", "Zhu D", "MacRae VE"], "date": "2023-12-05T00:00:00Z", "doi": "10.1038/s41598-023-47774-6", "meta_date_publication": "2023 Dec 5", "meta_volume": "13", "meta_issue": "1", "meta_pages": "21435", "score": 50271.445, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates valve interstitial cell @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@ by promoting autophagic flux", "citations": {"NLM": "Phadwal K, Tan X, Koo E, Zhu D, MacRae VE. Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux Sci Rep. 2023 Dec 5;13(1):21435. PMID: 38052777", "BibTeX": "@article{38052777, title={Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux}, author={Phadwal K and Tan X and Koo E and Zhu D and MacRae VE}, journal={Sci Rep}, volume={13}, number={1}, pages={21435}}"}}, {"_id": "34895136", "pmid": 34895136, "pmcid": "PMC8666063", "title": "Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way", "journal": "Mol Med", "authors": ["En Q", "Zeping H", "Yuetang W", "Xu W", "Wei W"], "date": "2021-12-11T00:00:00Z", "doi": "10.1186/s10020-021-00416-x", "meta_date_publication": "2021 Dec 11", "meta_volume": "27", "meta_issue": "1", "meta_pages": "156", "score": 50269.46, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@ induced by PM", "citations": {"NLM": "En Q, Zeping H, Yuetang W, Xu W, Wei W. Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way Mol Med. 2021 Dec 11;27(1):156. PMID: 34895136", "BibTeX": "@article{34895136, title={Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K/AKT pathway in an AMPK dependent way}, author={En Q and Zeping H and Yuetang W and Xu W and Wei W}, journal={Mol Med}, volume={27}, number={1}, pages={156}}"}}, {"_id": "37409753", "pmid": 37409753, "title": "Metformin prevents osteoblast-like potential and calcification in lung cancer A549 cells.", "journal": "J Biochem Mol Toxicol", "authors": ["Yadav P", "Makwana S", "Bansal S", "Soni S", "Mahapatra MK", "Bandyopadhayaya S", "Tailor R", "Shrivastava SK", "Sharma LK", "Mandal CC"], "date": "2023-07-06T00:00:00Z", "doi": "10.1002/jbt.23454", "meta_date_publication": "2023 Jul 6", "meta_volume": "", "meta_issue": "", "meta_pages": "e23454", "score": 50263.457, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ prevents osteoblast-like potential and @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@ in @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung cancer@@@ @CELLLINE_CVCL:0023 @@@A549@@@ cells.", "citations": {"NLM": "Yadav P, Makwana S, Bansal S, Soni S, Mahapatra MK, Bandyopadhayaya S, Tailor R, Shrivastava SK, Sharma LK, Mandal CC. Metformin prevents osteoblast-like potential and calcification in lung cancer A549 cells. J Biochem Mol Toxicol. 2023 Jul 6;():e23454. PMID: 37409753", "BibTeX": "@article{37409753, title={Metformin prevents osteoblast-like potential and calcification in lung cancer A549 cells.}, author={Yadav P and Makwana S and Bansal S and Soni S and Mahapatra MK and Bandyopadhayaya S and Tailor R and Shrivastava SK and Sharma LK and Mandal CC}, journal={J Biochem Mol Toxicol}, pages={e23454}}"}}, {"_id": "33365058", "pmid": 33365058, "pmcid": "PMC7716633", "title": "Metformin alleviates beta-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK/mTOR-activated autophagy", "journal": "Exp Ther Med", "authors": ["Qiu X", "Xu Q", "Xu T", "Wan P", "Sheng Z", "Han Y", "Yao L"], "date": "2021-01-01T00:00:00Z", "doi": "10.3892/etm.2020.9490", "meta_date_publication": "2021 Jan", "meta_volume": "21", "meta_issue": "1", "meta_pages": "58", "score": 50253.523, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ alleviates @CHEMICAL_beta_glycerophosphoric_acid @CHEMICAL_MESH:C031463 @@@beta-glycerophosphate@@@-induced @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@VSMC calcification@@@", "citations": {"NLM": "Qiu X, Xu Q, Xu T, Wan P, Sheng Z, Han Y, Yao L. Metformin alleviates beta-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK/mTOR-activated autophagy Exp Ther Med. 2021 Jan;21(1):58. PMID: 33365058", "BibTeX": "@article{33365058, title={Metformin alleviates beta-glycerophosphate-induced calcification of vascular smooth muscle cells via AMPK/mTOR-activated autophagy}, author={Qiu X and Xu Q and Xu T and Wan P and Sheng Z and Han Y and Yao L}, journal={Exp Ther Med}, volume={21}, number={1}, pages={58}}"}}, {"_id": "35869471", "pmid": 35869471, "pmcid": "PMC9306077", "title": "Metformin activates Wnt/beta-catenin for the treatment of diabetic osteoporosis", "journal": "BMC Endocr Disord", "authors": ["Huang X", "Li S", "Lu W", "Xiong L"], "date": "2022-07-22T00:00:00Z", "doi": "10.1186/s12902-022-01103-6", "meta_date_publication": "2022 Jul 22", "meta_volume": "22", "meta_issue": "1", "meta_pages": "189", "score": 50251.574, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@", "citations": {"NLM": "Huang X, Li S, Lu W, Xiong L. Metformin activates Wnt/beta-catenin for the treatment of diabetic osteoporosis BMC Endocr Disord. 2022 Jul 22;22(1):189. PMID: 35869471", "BibTeX": "@article{35869471, title={Metformin activates Wnt/beta-catenin for the treatment of diabetic osteoporosis}, author={Huang X and Li S and Lu W and Xiong L}, journal={BMC Endocr Disord}, volume={22}, number={1}, pages={189}}"}}, {"_id": "33513420", "pmid": 33513420, "title": "Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects.", "journal": "Free Radic Biol Med", "authors": ["Ma WQ", "Sun XJ", "Zhu Y", "Liu NF"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.freeradbiomed.2021.01.033", "meta_date_publication": "2021 Mar", "meta_volume": "165", "meta_issue": "", "meta_pages": "229-242", "score": 50251.254, "text_hl": "The aim of this study was to determine the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@ on ferroptosis induced by lipid overload and the effects of these changes on @DISEASE_Smooth_Muscle_Tumor @DISEASE_MESH:D018235 @@@vascular smooth muscle cells@@@ (@DISEASE_Smooth_Muscle_Tumor @DISEASE_MESH:D018235 @@@VSMCs@@@) @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@. ", "citations": {"NLM": "Ma WQ, Sun XJ, Zhu Y, Liu NF. Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic Biol Med. 2021 Mar;165():229-242. PMID: 33513420", "BibTeX": "@article{33513420, title={Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects.}, author={Ma WQ and Sun XJ and Zhu Y and Liu NF}, journal={Free Radic Biol Med}, volume={165}, pages={229-242}}"}}, {"_id": "36166694", "pmid": 36166694, "title": "Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.", "journal": "J Cell Physiol", "authors": ["Phadwal K", "Koo E", "Jones RA", "Forsythe RO", "Tang K", "Tang Q", "Corcoran BM", "Caporali A", "MacRae VE"], "date": "2022-11-01T00:00:00Z", "doi": "10.1002/jcp.30887", "meta_date_publication": "2022 Nov", "meta_volume": "237", "meta_issue": "11", "meta_pages": "4303-4316", "score": 50246.523, "text_hl": "@<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@Calcification@@@ was blunted in vascular smooth muscle cells (VSMCs) by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in a dose-dependent manner (0.5-1.5 mM) compared to control cells (p < 0.01). ", "citations": {"NLM": "Phadwal K, Koo E, Jones RA, Forsythe RO, Tang K, Tang Q, Corcoran BM, Caporali A, MacRae VE. Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor. J Cell Physiol. 2022 Nov;237(11):4303-4316. PMID: 36166694", "BibTeX": "@article{36166694, title={Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor.}, author={Phadwal K and Koo E and Jones RA and Forsythe RO and Tang K and Tang Q and Corcoran BM and Caporali A and MacRae VE}, journal={J Cell Physiol}, volume={237}, number={11}, pages={4303-4316}}"}}, {"_id": "34505282", "pmid": 34505282, "pmcid": "PMC7612651", "title": "Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance", "journal": "J Physiol", "authors": ["Hufnagel A", "Fernandez-Twinn DS", "Blackmore HL", "Ashmore TJ", "Heaton RA", "Jenkins B", "Koulman A", "Hargreaves IP", "Aiken CE", "Ozanne SE"], "date": "2022-02-01T00:00:00Z", "doi": "10.1113/JP281902", "meta_date_publication": "2022 Feb", "meta_volume": "600", "meta_issue": "4", "meta_pages": "903-919", "score": 50241.78, "text_hl": "Placentas from @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ untreated and @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated dams have reduced labyrinthine area and increased @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@", "citations": {"NLM": "Hufnagel A, Fernandez-Twinn DS, Blackmore HL, Ashmore TJ, Heaton RA, Jenkins B, Koulman A, Hargreaves IP, Aiken CE, Ozanne SE. Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance J Physiol. 2022 Feb;600(4):903-919. PMID: 34505282", "BibTeX": "@article{34505282, title={Maternal but not fetoplacental health can be improved by metformin in a murine diet-induced model of maternal obesity and glucose intolerance}, author={Hufnagel A and Fernandez-Twinn DS and Blackmore HL and Ashmore TJ and Heaton RA and Jenkins B and Koulman A and Hargreaves IP and Aiken CE and Ozanne SE}, journal={J Physiol}, volume={600}, number={4}, pages={903-919}}"}}, {"_id": "35282660", "pmid": 35282660, "title": "Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.", "journal": "Cardiovasc Diagn Ther", "authors": ["Kataoka Y", "Nicholls SJ", "Andrews J", "Uno K", "Kapadia SR", "Tuzcu EM", "Nissen SE", "Puri R"], "date": "2022-02-01T00:00:00Z", "doi": "10.21037/cdt-21-346", "meta_date_publication": "2022 Feb", "meta_volume": "12", "meta_issue": "1", "meta_pages": "77-87", "score": 50241.523, "text_hl": "Furthermore, the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group demonstrated plaques with a smaller @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ arc (median: 168.7  vs. 208.5 , P=0.008), shorter longitudinal length (media: 5.1 vs. 9.1 mm, P=0.04), and a lower frequency of cholesterol crystal (3.9% vs. 18.2%, P=0.01) and spotty @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@ (3.9% vs. 34.8%, P=0.008). ", "citations": {"NLM": "Kataoka Y, Nicholls SJ, Andrews J, Uno K, Kapadia SR, Tuzcu EM, Nissen SE, Puri R. Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis. Cardiovasc Diagn Ther. 2022 Feb;12(1):77-87. PMID: 35282660", "BibTeX": "@article{35282660, title={Plaque microstructures during metformin therapy in type 2 diabetic subjects with coronary artery disease: optical coherence tomography analysis.}, author={Kataoka Y and Nicholls SJ and Andrews J and Uno K and Kapadia SR and Tuzcu EM and Nissen SE and Puri R}, journal={Cardiovasc Diagn Ther}, volume={12}, number={1}, pages={77-87}}"}}, {"_id": "28202017", "pmid": 28202017, "pmcid": "PMC5311847", "title": "Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients", "journal": "Cardiovasc Diabetol", "authors": ["Mary A", "Hartemann A", "Liabeuf S", "Aubert CE", "Kemel S", "Salem JE", "Cluzel P", "Lenglet A", "Massy ZA", "Lalau JD", "Mentaverri R", "Bourron O", "Kamel S"], "date": "2017-02-15T00:00:00Z", "doi": "10.1186/s12933-017-0509-7", "meta_date_publication": "2017 Feb 15", "meta_volume": "16", "meta_issue": "1", "meta_pages": "24", "score": 50061.957, "text_hl": "Association between below-the-knee @<m>DISEASE_Calcinosis</m> @DISEASE_MESH:D002114 @@@calcification@@@ scores and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment", "citations": {"NLM": "Mary A, Hartemann A, Liabeuf S, Aubert CE, Kemel S, Salem JE, Cluzel P, Lenglet A, Massy ZA, Lalau JD, Mentaverri R, Bourron O, Kamel S. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients Cardiovasc Diabetol. 2017 Feb 15;16(1):24. PMID: 28202017", "BibTeX": "@article{28202017, title={Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients}, author={Mary A and Hartemann A and Liabeuf S and Aubert CE and Kemel S and Salem JE and Cluzel P and Lenglet A and Massy ZA and Lalau JD and Mentaverri R and Bourron O and Kamel S}, journal={Cardiovasc Diabetol}, volume={16}, number={1}, pages={24}}"}}]}